全文获取类型
收费全文 | 4547篇 |
免费 | 180篇 |
国内免费 | 73篇 |
专业分类
耳鼻咽喉 | 88篇 |
儿科学 | 102篇 |
妇产科学 | 93篇 |
基础医学 | 653篇 |
口腔科学 | 88篇 |
临床医学 | 423篇 |
内科学 | 1042篇 |
皮肤病学 | 66篇 |
神经病学 | 437篇 |
特种医学 | 337篇 |
外科学 | 406篇 |
综合类 | 48篇 |
预防医学 | 220篇 |
眼科学 | 70篇 |
药学 | 458篇 |
中国医学 | 1篇 |
肿瘤学 | 268篇 |
出版年
2022年 | 42篇 |
2021年 | 92篇 |
2020年 | 33篇 |
2019年 | 60篇 |
2018年 | 85篇 |
2017年 | 54篇 |
2016年 | 48篇 |
2015年 | 74篇 |
2014年 | 110篇 |
2013年 | 157篇 |
2012年 | 184篇 |
2011年 | 223篇 |
2010年 | 148篇 |
2009年 | 163篇 |
2008年 | 169篇 |
2007年 | 213篇 |
2006年 | 212篇 |
2005年 | 205篇 |
2004年 | 180篇 |
2003年 | 168篇 |
2002年 | 159篇 |
2001年 | 149篇 |
2000年 | 137篇 |
1999年 | 119篇 |
1998年 | 106篇 |
1997年 | 99篇 |
1996年 | 97篇 |
1995年 | 85篇 |
1994年 | 61篇 |
1993年 | 61篇 |
1992年 | 46篇 |
1991年 | 66篇 |
1990年 | 76篇 |
1989年 | 98篇 |
1988年 | 80篇 |
1987年 | 110篇 |
1986年 | 60篇 |
1985年 | 89篇 |
1984年 | 48篇 |
1983年 | 53篇 |
1982年 | 40篇 |
1981年 | 31篇 |
1980年 | 33篇 |
1979年 | 34篇 |
1978年 | 18篇 |
1977年 | 23篇 |
1974年 | 28篇 |
1973年 | 21篇 |
1972年 | 22篇 |
1971年 | 25篇 |
排序方式: 共有4800条查询结果,搜索用时 31 毫秒
101.
Liu SC; Palek J; Yi SJ; Nichols PE; Derick LH; Chiou SS; Amato D; Corbett JD; Cho MR; Golan DE 《Blood》1995,86(1):349-358
Southeast Asian ovalocytosis (SAO) is an asymptomatic trait characterized by rigid, poorly deformable red cells that resist invasion by several strains of malaria parasites. The underlying molecular genetic defect involves simple heterozygous state for a mutant band 3 protein, which contains a deletion of amino acids 400 through 408, linked with a Lys 56-to-Glu substitution (band 3-Memphis polymorphism). To elucidate the contribution of the mutant SAO band 3 protein to increased SAO red blood cell (RBC) rigidity, we examined the participation of the mutant SAO band 3 protein in increased band 3 attachment to the skeleton and band 3 oligomerization. We found first that SAO RBC skeletons retained more band 3 than normal cells and that this increased retention preferentially involved the mutant SAO band 3 protein. Second, SAO RBCs contained a higher percentage of band 3 oligomer-ankyrin complexes than normal cells, and these oligomers were preferentially enriched by the mutant SAO protein. At the ultrastructural level, the increased oligomer formation of SAO RBCs was reflected by stacking of band 3-containing intramembrane particles (IMP) into longitudinal strands. The IMP stacking was not reversed by treating SAO RBCs in alkaline pH (pH 11), which is known to weaken ankyrin-band 3 interactions, or by removing the cytoplasmic domain of band 3 from SAO membranes with trypsin. Finally, we found that band 3 protein in intact SAO RBCs exhibited a markedly decreased rotational mobility, presumably reflecting the increased oligomerization and the membrane skeletal association of the SAO band 3 protein. We propose that the mutant SAO band 3 has an increased propensity to form oligomers, which appear as longitudinal strands of IMP and exhibit increased association with membrane skeleton. This band 3 oligomerization underlies the increase in membrane rigidity by precluding membrane skeletal extension, which is necessary for membrane deformation. 相似文献
102.
Malendowicz LK Nowak M Gottardo L Tortorella C Majchrzak M Nussdorfer GG 《Endocrinology》2001,142(10):4251-4255
Cholecystokinin is a regulatory peptide, that acts through two subtypes of receptors, 1 and 2. RT-PCR demonstrated the expression of both cholecystokinin receptors 1 and 2 genes in the zona glomerulosa, but not the zona fasciculata-reticularis, of rat adrenals. Autoradiography demonstrated the presence of abundant [(125)I]cholecystokinin-binding sites in the zona glomerulosa, but not the zona fasciculata-reticularis, which were displaced by both cholecystokinin receptor 1- and 2-selective antagonists (cholecystokinin 1-A and 2-A). Cholecystokinin increased basal aldosterone secretion from dispersed zona glomerulosa cells without affecting corticosterone secretion from zona fasciculata-reticularis cells. The aldosterone response to cholecystokinin was blunted by cholecystokinin 1-A and 2-A, which when added together abolished it. ACTH-stimulated aldosterone production was not affected by cholecystokinin; in contrast, cholecystokinin potentiated aldosterone response to both angiotensin II and K(+). Cholecystokinin enhanced cAMP, but not IP(3), release by dispersed zona glomerulosa cells. The aldosterone response to cholecystokinin was abolished by the adenylate cyclase inhibitor SQ-22536 and the PKA inhibitor H-89, but not by either the PLC inhibitor U-73122 or the PKC inhibitor calphostin C. In conclusion, our study provides evidence that cholecystokinin, acting through cholecystokinin receptors 1 and 2 coupled with the adenylate cyclase/PKA cascade, exerts a sizeable secretagogue action on rat zona glomerulosa cells. 相似文献
103.
Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin 总被引:23,自引:3,他引:23
Interleukin-11 (IL-11) is a novel multifunctional hematopoietic cytokine capable of stimulating cells of the myeloid, lymphoid, erythroid, and megakaryocytic lineages in vitro. We have tested the pleiotropic properties of this cytokine on the hematopoietic recovery of mice after a combined regimen of sublethal irradiation and carboplatin administration. This regimen results in severe myelosuppression, characterized by a prolonged period of thrombocytopenia and severe anemia. Administration of recombinant human IL-11 (rhIL-11; 250 micrograms/kg/d) had multilineage effects on bone marrow and spleen hematopoietic activity, increasing the number of megakaryocyte, erythroid, granulocyte, and macrophage progenitors compared with the vehicle-treated controls. This was reflected in the peripheral circulation by a reduction of both the platelet and hematocrit nadirs and a significantly reduced period of thrombocytopenia and anemia in the rhIL-11-treated mice. The results from this study support the broad spectrum of biologic activities that have been attributed to rhIL-11 in vitro and suggest that this cytokine may be an effective agent in the treatment of myelosuppression associated with cancer chemotherapy and bone marrow transplantation. 相似文献
104.
O'Day SJ; Rabinowe SN; Neuberg D; Freedman AS; Soiffer RJ; Spector NA; Robertson MJ; Anderson K; Whelan M; Pesek K 《Blood》1994,83(9):2707-2714
Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) clearly hastens myeloid recovery in patients with relapsed hematologic malignancies undergoing autologous bone marrow transplantation (ABMT). In efforts to further improve neutrophil engraftment and shorten hospital stay in ABMT patients, rhGM-CSF was administered by a potentially more potent route (continuous infusion) to non-Hodgkin's lymphoma (NHL) patients with better BM reserve (first remission). Time to myeloid engraftment was compared with that of NHL patients treated in first remission at our institution on a similar ABMT protocol but without growth factor support (controls). Median neutrophil engraftment (absolute neutrophil count, 500 cells/microL) in first remission patients treated with rhGM-CSF was 14 days, compared with 22 days in controls (P = .0001). Hospital stays were also significantly reduced for rhGM-CSF patients (P = .0003). Platelet engraftment did not differ between the two groups. Persistent fever and generalized serositis were the primary toxicities. rhGM-CSF, delivered by this route, was efficacious but more toxic than 2-hour rhGM-CSF infusions previously reported by other investigators. Future alterations in both dose and schedule may retain comparable efficacy yet diminish toxicity. 相似文献
105.
Neal I. Lindeman Philip T. Cagle Dara L. Aisner Maria E. Arcila Mary Beth Beasley Eric H. Bernicker Carol Colasacco Sanja Dacic Fred R. Hirsch Keith Kerr David J. Kwiatkowski Marc Ladanyi Jan A. Nowak Lynette Sholl Robyn Temple-Smolkin Benjamin Solomon Lesley H. Souter Erik Thunnissen Yasushi Yatabe 《The Journal of molecular diagnostics : JMD》2018,20(2):129-159
106.
U. Nowak S. Eisenacher H. Braun F. Rausch S. Muszinski J. Thiem A. Becker S. Englisch P. Kirsch A. Meyer-Lindenberg M. Zink 《Cognitive therapy and research》2018,42(5):699-710
Several attributional biases have been discussed as putative causal factors in psychosis formation and maintenance. The monocausality bias in particular describes the excessive tendency to disregard multifactorial explanations and to instead attribute events to a single cause. To elucidate the role of monocausality in psychosis development, this study compared patients with an at-risk mental state of psychosis (ARMS, n?=?49), first-episode patients (FEP, n?=?35), chronic schizophrenia patients (SZ, n?=?32) and healthy controls (HC, n?=?39) on the Internal Personal and Situational Attributions Questionnaire—Revised. FEP patients made significantly more monocausal attributions than HC to the external-personal locus for positive events. Moreover, monocausality was linked with psychotic as well as depressive symptoms and tentatively also with a hasty data gathering style. Future studies should explore associations with other metacognitive deficits and the potential to prevent or correct the monocausality bias through psychological interventions. 相似文献
107.
Alicja Nowak Karolina Przybylowska-Sygut Mira Gacek Anna Kaminska Jacek P. Szaflik Jerzy Szaflik 《Ophthalmic genetics》2015,36(2):105-112
Background: Glaucoma is characterized by optic neuropathy of the retinal ganglion cell. It may be possible that β-amyloid (Aβ) and apolipoprotein E (APOE), the main proteins of the pathogenesis of AD, play a role in glaucoma development. The aim of this study was to evaluate a relationship between the APP and APOE gene polymorphisms and the risk of primary open-angle glaucoma (POAG) occurrence.Materials and methods: The study consisted of 183 patients with POAG and 209 healthy subjects. Genomic DNA was extracted from peripheral blood. Analysis of the gene polymorphisms was performed using PCR-RFLP.Results: We found a statistically significant increase of the -491?T allele frequency (p?=?0.02; OR?=?1.48; 95% CI?=?1.06–2.08) of APOE in POAG compared to healthy controls. There were no differences in the genotype and allele distributions and odds ratios of the APP polymorphism between patients and controls group. We also found an association between APOE polymorphic variant and retinal nerve fiber layer (RNFL). There was a statistically significant difference in the APOE gene A/T genotype frequency in the early POAG stage and middle-advanced POAG stage in comparison to the advanced POAG stage (p?=?0.04; OR?=?3.38; 95% CI?=?1.04–10.97).Conclusions: The -491?T allele of APOE polymorphism may be associated with a risk of POAG occurrence in the Polish population. 相似文献
108.
Sarah A Stuart Paul Butler Marcus R Munafò David J Nutt Emma SJ Robinson 《Neuropsychopharmacology》2015,40(9):2165-2174
The biochemical targets for antidepressants are relatively well established, but we lack a clear understanding of how actions at these proteins translate to clinical benefits. This study used a novel rodent assay to investigate how different antidepressant drugs act to modify affective biases that have been implicated in depression. In this bowl-digging task, rats encounter two equal value learning experiences on separate days (one during an affective manipulation and the other during control conditions). This induces an affective bias that is quantified using a preference test in which both digging substrates are presented together and the individual rats’ choices recorded. The assay can be used to measure affective biases associated with learning (when the treatment is given at the time of the experience) or examine the modification of previously acquired biases (when the treatment is administered before the preference test). The rapid-onset antidepressant ketamine, but not the delayed-onset antidepressant, venlafaxine, attenuated the previously acquired FG7142-induced negative bias following systemic administration. Venlafaxine but not ketamine induced a positive bias when administered before learning. We then used local drug infusions and excitotoxic lesions to localize the effects of ketamine to the medial prefrontal cortex and venlafaxine to the amygdala. Using a modified protocol we also showed that positive and negative biases amplified further when the numbers of substrate–reinforcer associations are increased. We propose that this pattern of results could explain the delayed onset of action of venlafaxine and the rapid onset of action but lack of long-term efficacy seen with ketamine. 相似文献
109.
Karvandi Elika Hanrahan John Gerrard Khan Danyal Zaman Boloux Pierre-Marc Bremner Fion Cabrilo Ivan Dorward Neil Grieve Joan Jackson Sue Jimenez Glenda Serrano Inma Nowak Victoria Anne Kolias Angelos Baldeweg Stephanie E. Marcus Hani Joseph 《Pituitary》2022,25(4):673-683
Pituitary - Pituitary adenomas affect patients’ quality-of-life (QoL) across several domains, with long-term implications even following gross-total resection or disease remission. While... 相似文献
110.